These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7679936)

  • 21. Calcium channel blockers in psychiatric disorders: a review of the literature.
    Hollister LE; Trevino ES
    Can J Psychiatry; 1999 Sep; 44(7):658-64. PubMed ID: 10500866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
    Massie BM
    Am J Cardiol; 1985 Dec; 56(16):97H-100H. PubMed ID: 2866709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia: review of treatments past, present, and future.
    Gupta S; Mosnik D; Black DW; Berry S; Masand PS
    Ann Clin Psychiatry; 1999 Dec; 11(4):257-66. PubMed ID: 10596740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC
    Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential synergistic effect of calcium channel blockers and alpha-tocopherol on gastric mucosal injury induced by ischaemia-reperfusion.
    al-Dohayan AD; al-Tuwaijri AS
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1107-10. PubMed ID: 8944374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockers in primary pulmonary hypertension.
    Rubin LJ
    Chest; 1985 Oct; 88(4 Suppl):257S-260S. PubMed ID: 4042732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
    Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
    Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel antagonists for the treatment of bipolar disorder.
    Levy NA; Janicak PG
    Bipolar Disord; 2000 Jun; 2(2):108-19. PubMed ID: 11252650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonists for Duchenne muscular dystrophy.
    Phillips MF; Quinlivan R
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004571. PubMed ID: 18843663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.